Reference
Schechet SA, et al. ACUTE RETINAL NECROSIS AFTER ADMINISTRATION OF ADALIMUMAB, A SYSTEMIC ANTITUMOR NECROSIS FACTOR ANTIBODY. Retinal Cases and Brief Reports 12: 307-309, No. 4, Oct 2018. Available from: URL: http://doi.org/10.1097/ICB.0000000000000499 - USA
Rights and permissions
About this article
Cite this article
Adalimumab. Reactions Weekly 1724, 14 (2018). https://doi.org/10.1007/s40278-018-52993-5
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40278-018-52993-5